Now I have all the verification I need. Let me produce the final consolidated review.

---

## Summary

GRABLI proposes a self-supervised cross-modal pre-training method that aligns a biomedical language model (LM) with a biomedical knowledge graph (UMLS) via contrastive learning. It jointly trains a GNN-based KG encoder alongside the LM, using concept mentions in text as anchors to pull textual entity representations and KG subgraph representations into a shared embedding space. The key empirical claim is that this lightweight alignment (65K steps, 1.7M sentences, 600K concepts) consistently improves PubMedBERT and BioLinkBERT on question answering (PubMedQA, MedQA, BioASQ) and entity linking (NCBI, BC5CDR, BC2GN, SMM4H), with the most striking gains in zero-shot entity linking (e.g., +24.2% Acc@1 for BioLinkBERT_base).

## Strengths

- **Consistent and non-trivial gains on multiple QA benchmarks after lightweight pre-training.** GRABLI improves PubMedBERT by +2.1% on PubMedQA, +1.7% on MedQA, and +6.2% on BioASQ (Table 1). These gains are achieved with only 1.7M sentences and 600K UMLS concepts, demonstrating data efficiency.
- **Systematic comparison of graph representation methods answering RQ2 and RQ3.** The paper evaluates GAT, GraphSAGE, DistMult, TransE, linearized graphs, and purely textual node representations (Table 3). The finding that GAT outperforms mean-pooling (GraphSAGE) by 6.4% on PubMedQA confirms the value of attention-based aggregation, while the strong performance of linearized graphs provides actionable guidance for practitioners.
- **GRABLI enables general-purpose biomedical LMs to match task-specific entity linking models with substantially less data.** After GRABLI pre-training, BioLinkBERT_base performs on par with SapBERT (pre-trained on 12M UMLS triples) on BC5CDR-Disease and BC5CDR-Chem (Table 2). In the supervised SMM4H setting, GRABLI adds 2.4% Acc@1 on top of SapBERT itself.
- **Thorough ablation of training objectives and architectural choices.** Table 4 ablates the MLM loss, the alignment loss, different token-entity aggregation methods, and GNN depth, justifying each modeling decision and showing that both losses are necessary.

## Weaknesses

### Fatal

None.

### Major

- **Relation extraction evaluation is claimed but results are entirely absent.** Section 5.1 states: "Additionally, we perform evaluation on three biomedical relation extraction datasets (ChemProt, DDI, GAR)." The paper never returns to these results — no table, no figure, no text describes RE performance. The contribution is framed as a general-purpose LM-KG alignment method; omitting an entire evaluation category that the paper itself promised leaves the empirical case incomplete. The authors must either add these results or remove the claim.

### Minor

- **No variance estimates for MedQA results.** The paper reports standard deviations only for PubMedQA and BioASQ (10 runs each), explicitly stating this is "due to small dataset sizes and fine-tuning instability." MedQA, the largest dataset (12,723 questions), has no reported variance despite smaller absolute gains (e.g., PubMedBERT 36.4 → GRABLI GNN 38.1, a +1.7% absolute gain). Without confidence intervals or multi-seed reporting, the reader cannot distinguish robust improvements from noise for MedQA specifically. This does not threaten the paper's core claim (which is supported by multiple datasets), but it weakens confidence in the MedQA result.
- **Downstream fine-tuning details for QA are underspecified.** The paper provides thorough pre-training details (65K steps, batch size 256, learning rates, optimizer) but does not describe the fine-tuning setup for QA datasets — number of epochs, learning rate, batch size, whether the whole model is fine-tuned or only a classifier head. This information is needed for reproducibility.
- **The "supervised" entity linking setup lacks clarity.** The paper states "supervised approach based on BioSyn" but does not specify whether the LM backbone is fine-tuned during this stage or only the BioSyn retrieval scorer is trained. Clarification would help.
- **Temperature τ and batch size B are not ablated.** The InfoNCE objective is known to be sensitive to both hyperparameters. While the paper provides useful ablations on loss functions and GNN depth, the absence of a sensitivity analysis for τ and B leaves a plausible alternative explanation for some performance variation. This is a gap in an otherwise thorough ablation study.

## Trivial

None.

## Nice-to-Haves

- A dedicated limitations section discussing when GRABLI helps most (large zero-shot gains) and where gains are marginal (e.g., some supervised EL settings).
- FLOPs or wall-time comparison between GNN and linearization approaches to make the RQ3 guidance more concrete.
- Sensitivity analysis on temperature τ and batch size B for the InfoNCE loss.

## Removed Points

These points were flagged but are excluded from the main review for the following reasons:
- **QA-GNN/GreaseLM comparison framing**: The critic notes that QA-GNN and GreaseLM are inference-time reasoning models whereas GRABLI is a pre-training method, and suggests the "performs on par or better" framing could be misleading. However, the paper already explicitly notes that QA-GNN and GreaseLM are "task-specific" and share the same backbone LM (BioLinkBERT_large), and the comparison is presented as informative rather than a direct apples-to-apples benchmark. The framing is appropriately caveated; this is a minor presentation choice, not a weakness.
- **Absence of a limitations section**: Important for completeness but too low in severity for the Weaknesses section; moved to Nice-to-Haves.

## Novel Insights

None beyond the paper's own contributions. The cross-check between reviewer viewpoints confirms that the core methodological contribution is well-recognized, and the missing RE results and reproducibility gaps are the primary actionable concerns.

## Suggestions

1. **Add the missing relation extraction results** in a new table or subsection, or remove the claim that RE evaluation was performed. This is the single most important fix.
2. **Report multi-seed or bootstrapped confidence intervals for MedQA**, or at minimum explicitly state whether single-run or multi-run evaluation was used, and clarify why variance is not reported for the largest dataset.
3. **Add a brief "Fine-tuning Details" paragraph** in the appendix or Evaluation Setup section covering the downstream QA setup (epochs, learning rate, batch size, whether full fine-tuning or linear probing).
4. **Clarify what "supervised" means for entity linking** — is the LM fine-tuned during BioSyn training, or only the scorer?
5. **Consider ablating temperature τ and batch size B** for the InfoNCE loss, or at minimum state the chosen values and justify them.

## Score and Decision

The paper presents a well-motivated and clearly described pre-training method with consistent gains across QA and entity linking, a thorough ablation study, and a useful comparison of graph representation approaches. The main empirical weakness is the missing relation extraction results, which the paper itself promised; this is a fixable gap rather than a structural flaw, but it must be addressed. The remaining issues (MedQA variance, fine-tuning details, hyperparameter sensitivity) are minor. Overall, the paper makes a solid contribution to biomedical LM-KG alignment.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>